Keyword | CPC | PCC | Volume | Score | Length of keyword |
---|---|---|---|---|---|
venetoclax cll | 1.22 | 0.4 | 4899 | 22 | 14 |
venetoclax | 1.65 | 0.5 | 7893 | 8 | 10 |
cll | 0.97 | 0.2 | 256 | 16 | 3 |
Keyword | CPC | PCC | Volume | Score |
---|---|---|---|---|
venetoclax cll | 1.04 | 0.3 | 6753 | 89 |
venetoclax cll protocol | 1.32 | 0.5 | 6342 | 75 |
venetoclax cll fda | 0.61 | 0.4 | 1696 | 44 |
venetoclax cll side effects | 0.46 | 0.8 | 4668 | 25 |
venetoclax cll ramp up | 1.46 | 0.4 | 2760 | 89 |
venetoclax cll dosierung | 1.73 | 0.6 | 9334 | 80 |
venetoclax cll 11q | 1.61 | 0.1 | 4116 | 100 |
venetoclax cll nice | 0.26 | 0.5 | 1135 | 75 |
venetoclax cll approval | 1.03 | 0.2 | 3777 | 68 |
venetoclax cll calendar | 1.1 | 0.3 | 3589 | 22 |
venetoclax cll indication | 1.67 | 0.2 | 8190 | 60 |
venetoclax cll package insert | 0.08 | 0.9 | 5130 | 13 |
venetoclax cll fda approval | 1.81 | 0.4 | 4091 | 90 |
venetoclax dosing schedule in cll | 1.86 | 0.5 | 1137 | 60 |
venetoclax dosing in cll | 0.59 | 0.2 | 6872 | 56 |
obinutuzumab venetoclax relapsed cll | 0.2 | 0.8 | 9787 | 15 |
gazyva and venetoclax for cll protocol | 0.29 | 0.7 | 8331 | 41 |
venetoclax treatment for cll | 0.09 | 1 | 3072 | 25 |
venetoclax mechanism of action cll | 0.49 | 0.6 | 7789 | 65 |
venetoclax obinutuzumab cll | 0.59 | 0.2 | 9188 | 12 |
venetoclax monotherapy cll | 0.59 | 0.5 | 2324 | 50 |